Go backIncome
Assets
Equity
Liabilities
Other
Societatea cu Răspundere Limitată CES PHARM
CES PHARM
is not in process of liquidation on Apr 30, 2024
To view all financial indicators, unlock this company.
Income
Financial indicator20212020
Net sales
-
157K MDL
-81%
Cost of goods sold
-
░░░░░░░░
Gross profit
-
░░░░░░░░
Distribution expenses
-
░░░░░░░░
Administrative expenses
░░░░░░░░
0%
░░░░░░░░
Other operating expenses
-
░░░░░░░░
Operating profit
░░░░░░░░
0%
░░░░░░░░
0%
Profit before tax
░░░░░░░░
0%
░░░░░░░░
0%
Net profit
-58.1K MDL
47%
-111K MDL
54%
Assets
Financial indicator20212020
Total assets
925K MDL
-30%
1.30M MDL
1%
Current assets
░░░░░░░░
0%
░░░░░░░░
0%
Equity
Financial indicator20212020
Equity
░░░░░░░░
0%
░░░░░░░░
0%
Share capital
░░░░░░░░
0%
░░░░░░░░
Profit and loss reserves
░░░░░░░░
0%
░░░░░░░░
Liabilities
Financial indicator20212020
Total liabilities
-
-
Short-term liabilities
░░░░░░░░
0%
░░░░░░░░
0%
Long-term liabilities
░░░░░░░░
0%
░░░░░░░░
0%
Your trusted source for business data
Socials
English, USA
English, USA